Trivitron launches IVD
Trivitron Healthcare Systems along with the Spain-based Biosystems today launched its first state-of-the-art In Vitro Diagnostics (IVD) manufacturing facility for the Indian and emerging markets of the world.
The facility, inaugurated by SIPCOT Managing Director Swaran Singh, would manufacture In Vitro Diagnostics reagent in India for the emerging markets.
It was located at the Trivitron Medical Technology Park at Sriperumbudur, about 40 km from the city.
"This is another feather in the cap of Tamil Nadu's contribution to healthcare segment" Mr Singh said here today, adding,the state was already the leader in healthcare delivery in the country and was the choicest destination for international medical tourism.
"With healthcare costs becoming prohibitive, it is imperative that initiatives like this one be promoted aggressively", he added.
Speaking on the occasion, Dr G S K Velu of Trivitron said this plant would be incorporating all contemporary technologies and comply with European standards for its operations and would be on par with the global standards in every way.
"The plant design is scalable to double the capacity in future. This facility will produce reagent worth over Rs 200 crore during the next 3 to 5 years and it would not only cater to the domestic market but also supply to the other overseas markets", he added.